We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Aches
- Critically Illness
- Immature Newborn
- In-stent Restenosis
- Lichen Planus Pigmentosus
- Limb Deformity
- Parvovirus B19 Infection
- Qt Interval, Variation in
- Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
- Secondhand Smoking
- Sleep Apnea Hypopnea Syndrome
- Stage III Childhood Hodgkin Lymphoma
- Stenotic Coronary Lesion
- View Full List
Sponsors and Collaborators
- C. Michael Dunham
- Cereve, Inc.
- Iole Cordone
- Kerbi Alejandro Guevara-Noriega
- Lo-Sheng Sanatorium
- NHS Greater Glasgow and Clyde Board HQ
- Office of the Vice Chancellor for Research and Graduate Education
- OseoAnvar
- PrecisionOS Technology
- Rite Aid Corp.
- Silesian Hospital Opava
- US Army Combat Capabilities Development Command- Soldier Center
- Université de Rennes, Laboratoire du Traitement du Signal et de l'Image (LTSI)
- View Full List
Drug Interventions
- 2% lidocaine with 1:80,000 epinephrine
- AGN-210669 ophthalmic solution, 0.05%
- Ciclesonide nasal
- H pylori eradication
- Lamivudine plus adefovir
- Levofloxacin 0.5%
- Liposomal daunorubicin
- Octagam 10%
- Olaparib tablet dosing
- Prochlorperazine
- SYR-619
- TLR4 Agonist GLA-SE
- Thymoglobulin (anti-thymocyte globulin)
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations